JCO YOUNG INVESTIGATOR AWARD

Journal Honors Wei Ai, MD, PhD, as Recipient of the 2005 JCO Young Investigator Award

JCO May 20 2005: 3295–3296. [Full Text] [PDF]

IN MEMORIAM

Byrl James Kennedy, MD

Hyman B. Muss

JCO May 20 2005: 3297–3298. [Full Text] [PDF]

EDITORIALS

Progress in the Management of Bone Metastases: One Continent at a Time?

Gabriel N. Hortobagyi

JCO May 20 2005: 3299–3301. First published on Feb 28 2005; 10.1200/JCO.2005.11.931. [Full Text] [PDF]

Prostate Cancer Chemotherapy: Emerging From the Shadows

Bruce J. Roth

JCO May 20 2005: 3302–3303. First published on Feb 28 2005; 10.1200/JCO.2005.11.933. [Full Text] [PDF]

What Is More Exciting? The Activity of Docetaxel in Early Prostate Cancer or the Successful Collaboration Between Urologists and Medical Oncologists to Complete a Study in Early Prostate Cancer?

Michael A. Carducci

JCO May 20 2005: 3304–3307. First published on Feb 28 2005; 10.1200/JCO.2005.11.934. [Full Text] [PDF]

Radiation Therapy Alone for Spinal Cord Compression: Time to Improve Upon a Relatively Ineffective Status Quo

Young Kwok, William F. Regine, and Roy A. Patchell

JCO May 20 2005: 3308–3310. First published on Feb 28 2005; 10.1200/JCO.2005.11.940. [Full Text] [PDF]

COMMENTS AND CONTROVERSIES

FOLFOX for Stage II Colon Cancer? A Commentary on the Recent FDA Approval of Oxaliplatin for Adjuvant Therapy of Stage III Colon Cancer

Axel Grothey and Daniel J. Sargent

JCO May 20 2005: 3311–3313. [Full Text] [PDF]

ORIGINAL REPORTS
Breast Cancer
	Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial
	Norio Kohno, Kenjiro Aogi, Hironobu Minami, Seigo Nakamura, Taro Asaga, Yuichi Iino, Toru Watanabe, Carsten Goessl, Yasuo Ohashi, and Shigemitsu Takashima
	JCO May 20 2005: 3314–3321. First published on Feb 28 2005; 10.1200/JCO.2005.05.116. [Abstract] [Full Text] [PDF]
	Quality of Life Among Younger Women With Breast Cancer
	Nancy E. Avis, Sybil Crawford, and Janeen Manuel
	JCO May 20 2005: 3322–3330. [Abstract] [Full Text] [PDF]
	Changes in Gene Expression Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer
	Juliane Hannemann, Hendrika M. Oosterkamp, Cathy A.J. Bosch, Arno Velds, Lodewyk F.A. Wessels, Claudette Loo, Emiel J. Rutgers, Sjoerd Rodenhuis, and Marc J. van de Vijver
	JCO May 20 2005: 3331–3342. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Multicenter Randomized Phase II Study of Two Schedules of Docetaxel, Estramustine, and Prednisone Versus Mitoxantrone Plus Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
	Stéphane Oudard, Eugeniu Banu, Philippe Beuzeboc, Eric Voog, Louis Marie Dourthe, Anne Claire Hardy-Bessard, Claude Linassier, Florian Scotté, Adela Banu, Yvan Coscas, François Guinet, Marie-France Poupon, and Jean-Marie Andrieu
	JCO May 20 2005: 3343–3351. First published on Feb 28 2005; 10.1200/JCO.2005.12.187. [Abstract] [Full Text] [PDF]
	Effect of Docetaxel in Patients With Hormone-Dependent Prostate-Specific Antigen Progression After Local Therapy for Prostate Cancer
	Susan Goodin, Patrick Medina, Terry Capanna, Weichung J. Shih, Sybil Abraham, Jessica Winnie, Susan Doyle-Lindrud, Mary Todd, and Robert S. DiPaola
	JCO May 20 2005: 3352–3357. First published on Feb 28 2005; 10.1200/JCO.2005.11.111. [Abstract] [Full Text] [PDF]

Radiation Oncology
	Short-Course Versus Split-Course Radiotherapy in Metastatic Spinal Cord Compression: Results of a Phase III, Randomized, Multicenter Trial
	Ernesto Maranzano, Rita Bellavita, Romina Rossi, Verena De Angelis, Alessandro Frattegiani, Rita Bagnoli, Marcello Mignogna, Sara Beneventi, Marco Lupattelli, Pietro Ponticelli, Gian Paolo Biti, and Paolo Latini
	JCO May 20 2005: 3358–3365. First published on Feb 28 2005; 10.1200/JCO.2005.08.193. [Abstract] [Full Text] [PDF]
	Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression
	Dirk Rades, Lukas J.A. Stalpers, Theo Veninga, Rainer Schulte, Peter J. Hoskin, Nermina Obralic, Amira Bajrovic, Volker Rudat, Rudolf Schwarz, Maarten C. Hulshof, Philip Poortmans, and Steven E. Schild
	JCO May 20 2005: 3366–3375. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group
	Stacey L. Berg, Susan M. Blaney, Meenakshi Devidas, Tom A. Lampkin, Anthony Murgo, Mark Bernstein, Amy Billett, Joanne Kurtzberg, Greg Reaman, Paul Gaynon, James Whitlock, Mark Krailo, and Michael B. Harris
	JCO May 20 2005: 3376–3382. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma
	Mathias J. Rummel, Salah E. Al-Batran, Soo-Z. Kim, Manfred Welslau, Ralf Hecker, Dorothea Kofahl-Krause, Klaus-M. Josten, Heinz Dürk, Andreas Rost, Michael Neise, Ulrich von Grünhagen, Kai U. Chow, Martin-L. Hansmann, Dieter Hoelzer, and Paris S. Mitrou
	JCO May 20 2005: 3383–3389. [Abstract] [Full Text] [PDF]
	The Cutaneous B-Cell Lymphoma Prognostic Index: A Novel Prognostic Index Derived From a Population-Based Registry
	Benjamin D. Smith, Grace L. Smith, Dennis L. Cooper, and Lynn D. Wilson
	JCO May 20 2005: 3390–3395. [Abstract] [Full Text] [PDF]
	Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies
	J. Kurtzberg, T.J. Ernst, M.J. Keating, V. Gandhi, J.P. Hodge, D.F. Kisor, J.J. Lager, C. Stephens, J. Levin, T. Krenitsky, G. Elion, and B.S. Mitchell
	JCO May 20 2005: 3396–3403. [Abstract] [Full Text] [PDF]
	Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity
	Guido Marcucci, Wendy Stock, Guowei Dai, Rebecca B. Klisovic, Shujun Liu, Marko I. Klisovic, William Blum, Cheryl Kefauver, Dorie A. Sher, Margaret Green, Mollie Moran, Kati Maharry, Steven Novick, Clara D. Bloomfield, James A. Zwiebel, Richard A. Larson, Michael R. Grever, Kenneth K. Chan, and John C. Byrd
	JCO May 20 2005: 3404–3411. First published on Apr 11 2005; 10.1200/JCO.2005.09.118. [Abstract] [Full Text] [PDF]
	International Staging System for Multiple Myeloma
	Philip R. Greipp, Jesus San Miguel, Brian G.M. Durie, John J. Crowley, Bart Barlogie, Joan Bladé, Mario Boccadoro, J. Anthony Child, Hervé Avet-Loiseau, Robert A. Kyle, Juan J. Lahuerta, Heinz Ludwig, Gareth Morgan, Raymond Powles, Kazuyuki Shimizu, Chaim Shustik, Pieter Sonneveld, Patrizia Tosi, Ingemar Turesson, and Jan Westin
	JCO May 20 2005: 3412–3420. First published on Apr 4 2005; 10.1200/JCO.2005.04.242. [Abstract] [Full Text] [PDF]

Immunotherapy
	Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma Modulates Intratumoral CD4/CD8 Ratio and Tumor Microenvironment: A Multicenter Phase II Clinical Trial
	József Tímár, Andrea Ladányi, Csaba Forster-Horváth, Júlia Lukits, Balázs Döme, Éva Remenár, Mária Godény, Miklós Kásler, Beáta Bencsik, Gábor Répássy, György Szabó, Norbert Velich, Zsuzsa Suba, János Élo, Zsuzsa Balatoni, Károly Pócza, Béla Zemplén, Paul Chretien, and Eyal Talor
	JCO May 20 2005: 3421–3432. [Abstract] [Full Text] [PDF]

Bone Marrow Transplantation
	Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of Unmutated VH Gene in Patients With Chronic Lymphocytic Leukemia
	Carol Moreno, Neus Villamor, Dolors Colomer, Jordi Esteve, Rodrigo Martino, Josep Nomdedéu, Francesc Bosch, Armando López-Guillermo, Elías Campo, Jorge Sierra, and Emili Montserrat
	JCO May 20 2005: 3433–3438. First published on Apr 4 2005; 10.1200/JCO.2005.04.531. [Abstract] [Full Text] [PDF]
	Ablative Allogeneic Hematopoietic Cell Transplantation in Adults 60 Years of Age and Older
	Herschel Wallen, Theodore A. Gooley, H. Joachim Deeg, John M. Pagel, Oliver W. Press, Frederick R. Appelbaum, Rainer Storb, and Ajay K. Gopal
	JCO May 20 2005: 3439–3446. First published on Apr 11 2005; 10.1200/JCO.2005.05.694. [Abstract] [Full Text] [PDF]
	Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of Relapse
	Franco Aversa, Adelmo Terenzi, Antonio Tabilio, Franca Falzetti, Alessandra Carotti, Stelvio Ballanti, Rita Felicini, Flavio Falcinelli, Andrea Velardi, Loredana Ruggeri, Teresa Aloisi, Jean Pierre Saab, Antonella Santucci, Katia Perruccio, Maria Paola Martelli, Cristina Mecucci, Yair Reisner, and Massimo F. Martelli
	JCO May 20 2005: 3447–3454. First published on Mar 7 2005; 10.1200/JCO.2005.09.117. [Abstract] [Full Text] [PDF]

Genetic Testing for Cancer
	Randomized Comparison of Group Versus Individual Genetic Education and Counseling for Familial Breast and/or Ovarian Cancer
	Kathleen A. Calzone, Sheila A. Prindiville, Oxana Jourkiv, Jean Jenkins, Maria DeCarvalho, Dawn B. Wallerstedt, David J. Liewehr, Seth M. Steinberg, Peter W. Soballe, Stan Lipkowitz, Pamela Klein, and Ilan R. Kirsch
	JCO May 20 2005: 3455–3464. [Abstract] [Full Text] [PDF]

Surgical Oncology
	Phase I Study of Hepatic Arterial Melphalan Infusion and Hepatic Venous Hemofiltration Using Percutaneously Placed Catheters in Patients With Unresectable Hepatic Malignancies
	James F. Pingpank, Steven K. Libutti, Richard Chang, Bradford J. Wood, Ziv Neeman, Anthony W. Kam, William D. Figg, Souping Zhai, Tatiana Beresneva, Geoffrey D. Seidel, and H. Richard Alexander
	JCO May 20 2005: 3465–3474. [Abstract] [Full Text] [PDF]
	Clinical Examination Following Preoperative Chemoradiation for Rectal Cancer Is Not a Reliable Surrogate End Point
	Jose G. Guillem, David B. Chessin, Jinru Shia, Harvey G. Moore, Madhu Mazumdar, Bianca Bernard, Philip B. Paty, Leonard Saltz, Bruce D. Minsky, Martin R. Weiser, Larissa K.F. Temple, Alfred M. Cohen, and W. Douglas Wong
	JCO May 20 2005: 3475–3479. [Abstract] [Full Text] [PDF]

Lung Cancer
	Phase II Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non–Small-Cell Lung Cancer: Promising Long-Term Results of the Radiation Therapy Oncology Group—RTOG 9705
	Jeffrey D. Bradley, Rebecca Paulus, Mary V. Graham, David S. Ettinger, David W. Johnstone, Miljenko V. Pilepich, Mitchell Machtay, Ritsuko Komaki, James Atkins, and Walter J. Curran
	JCO May 20 2005: 3480–3487. [Abstract] [Full Text] [PDF]
	Phase II Study of Irinotecan Plus Cisplatin Induction Followed by Concurrent Twice-Daily Thoracic Irradiation With Etoposide Plus Cisplatin Chemotherapy for Limited-Disease Small-Cell Lung Cancer
	Ji-Youn Han, Kwan Ho Cho, Dae Ho Lee, Hyae Young Kim, Eun-A Kim, Sung Young Lee, and Jin Soo Lee
	JCO May 20 2005: 3488–3494. [Abstract] [Full Text] [PDF]

Clinical Trials
	Phase II Study of a Liposome-Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally and Pathologic Response Rates in Patients With Malignant Pleural Mesothelioma
	Charles Lu, Roman Perez-Soler, Bilal Piperdi, Garrett L. Walsh, Stephen G. Swisher, W. Roy Smythe, Hyung J. Shin, Jae Y. Ro, Lei Feng, Mylene Truong, Adiseshu Yalamanchili, Gabriel Lopez-Berestein, Waun K. Hong, Abdul R. Khokhar, and Dong M. Shin
	JCO May 20 2005: 3495–3501. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer
	Herbert I. Hurwitz, Louis Fehrenbacher, John D. Hainsworth, William Heim, Jordan Berlin, Eric Holmgren, Julie Hambleton, William F. Novotny, and Fairooz Kabbinavar
	JCO May 20 2005: 3502–3508. [Abstract] [Full Text] [PDF]
	Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
	C. Louvet, R. Labianca, P. Hammel, G. Lledo, M.G. Zampino, T. André, A. Zaniboni, M. Ducreux, E. Aitini, J. Taïeb, R. Faroux, C. Lepere, and A. de Gramont
	JCO May 20 2005: 3509–3516. [Abstract] [Full Text] [PDF]
	Clinical Value of Mitochondrial Mutations in Colorectal Cancer
	Astrid Lièvre, Caroline Chapusot, Anne-Marie Bouvier, Franck Zinzindohoué, Françoise Piard, Patrick Roignot, Laurent Arnould, Philippe Beaune, Jean Faivre, and Pierre Laurent-Puig
	JCO May 20 2005: 3517–3525. [Abstract] [Full Text] [PDF]
	Molecular Staging for Survival Prediction of Colorectal Cancer Patients
	Steven Eschrich, Ivana Yang, Greg Bloom, Ka Yin Kwong, David Boulware, Alan Cantor, Domenico Coppola, Mogens Kruhøffer, Lauri Aaltonen, Torben F. Orntoft, John Quackenbush, and Timothy J. Yeatman
	JCO May 20 2005: 3526–3535. [Abstract] [Full Text] [PDF]
	Molecular Determinants of Cetuximab Efficacy
	Daniel Vallböhmer, Wu Zhang, Michael Gordon, Dong Yun Yang, Jim Yun, Oliver A. Press, Katrin E. Rhodes, Andy E. Sherrod, Syma Iqbal, Kathleen D. Danenberg, Susan Groshen, and Heinz-Josef Lenz
	JCO May 20 2005: 3536–3544. [Abstract] [Full Text] [PDF]
	Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study
	Javier Sastre, Eugenio Marcuello, Bartomeu Masutti, Matilde Navarro, Silvia Gil, Antonio Antón, Albert Abad, Enrique Aranda, Joan Maurel, Manuel Valladares, Inmaculada Maestu, Alfredo Carrato, José María Vicent, and Eduardo Díaz-Rubio
	JCO May 20 2005: 3545–3551. [Abstract] [Full Text] [PDF]

Treatment-Related Complications
	Patient Online Self-Reporting of Toxicity Symptoms During Chemotherapy
	Ethan Basch, David Artz, Dorothy Dulko, Kevin Scher, Paul Sabbatini, Martee Hensley, Nandita Mitra, John Speakman, Mary McCabe, and Deborah Schrag
	JCO May 20 2005: 3552–3561. [Abstract] [Full Text] [PDF]

Head and Neck Cancer
	Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group
	Michael K. Gibson, Yi Li, Barbara Murphy, Maha H.A. Hussain, Ronald C. DeConti, John Ensley, and Arlene A. Forastiere
	JCO May 20 2005: 3562–3567. [Abstract] [Full Text] [PDF]
	Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
	Anthony T.C. Chan, Mow-Ming Hsu, Boon C. Goh, Edwin P. Hui, Tsang-Wu Liu, Michael J. Millward, Ruey-Long Hong, Jacqueline Whang-Peng, Brigette B.Y. Ma, Ka F. To, Matthias Mueser, Nadia Amellal, Xiao Lin, and Alex Y. Chang
	JCO May 20 2005: 3568–3576. First published on Apr 4 2005; 10.1200/JCO.2005.02.147. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Home-Based Physical Activity Intervention for Breast Cancer Patients
	Bernardine M. Pinto, Georita M. Frierson, Carolyn Rabin, Joseph J. Trunzo, and Bess H. Marcus
	JCO May 20 2005: 3577–3587. [Abstract] [Full Text] [PDF]
	Couples Who Get Closer After Breast Cancer: Frequency and Predictors in a Prospective Investigation
	Michel Dorval, Stéphane Guay, Myrto Mondor, Benoît Mâsse, Maurice Falardeau, André Robidoux, Luc Deschênes, and Elizabeth Maunsell
	JCO May 20 2005: 3588–3596. [Abstract] [Full Text] [PDF]

Sarcomas
	Phase II Study of 9-Nitro-Camptothecin in Patients With Advanced Chordoma or Soft Tissue Sarcoma
	Rashmi Chugh, Rodney Dunn, Mark M. Zalupski, J. Sybil Biermann, Vernon K. Sondak, Joseph R. Mace, Kirsten M. Leu, William F. Chandler, and Laurence H. Baker
	JCO May 20 2005: 3597–3604. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Neoplastic Meningitis
	Marc C. Chamberlain
	JCO May 20 2005: 3605–3613. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Mapping Molecular Networks Using Proteomics: A Vision for Patient-Tailored Combination Therapy
	Emanuel F. Petricoin, III, Verena E. Bichsel, Valerie S. Calvert, Virginia Espina, Mary Winters, Lynn Young, Claudio Belluco, Bruce J. Trock, Marc Lippman, David A. Fishman, Dennis C. Sgroi, Peter J. Munson, Laura J. Esserman, and Lance A. Liotta
	JCO May 20 2005: 3614–3621. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Difficult Diagnostic Cases: CASE 1. Melanoma in African Americans

Jonathan E. Dowell, Yuenan Shen, William V. Harford, and Wen S. Lai

JCO May 20 2005: 3622–3624. [Full Text] [PDF]

Difficult Diagnostic Cases: CASE 2. Hemangioblastomas: Diagnosis of von Hippel-Lindau Disease and Antiangiogenic Treatment With SU5416

Gunter Schuch, Maike de Wit, Jan Höltje, Eckart Laack, Georgia Schilling, Dieter K. Hossfeld, Walter Fiedler, Paul Scigalla, and Mark S. Jacobs

JCO May 20 2005: 3624–3626. [Full Text] [PDF]

Difficult Diagnostic Cases: CASE 3. Oncogenic Osteomalacia Associated With Hemangiopericytoma Localized by Octreotide Scan

Paranee Auethavekiat, Jefferson R. Roberts, Timothy J. Biega, Morakinyo O. Toney, Reed S. Christensen, Christina M. Belnap, and Jeffrey L. Berenberg

JCO May 20 2005: 3626–3628. [Full Text] [PDF]

ART OF ONCOLOGY

Silence Is Not Golden: Communicating With Children Dying From Cancer

Estela A. Beale, Walter F. Baile, and Joann Aaron

JCO May 20 2005: 3629–3631. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

What You May Learn From the Dutch Experience

Mandy van den Brink, Wilbert B. van den Hout, Anne M. Stiggelbout, Job Kievit, and Cornelis J.H. van de Velde

JCO May 20 2005: 3632–3633. [Full Text] [PDF]

In Reply:

Marko Simunovic, Amiram Gafni, and Mark Levine

JCO May 20 2005: 3633–3634. [Full Text] [PDF]

Cardiac Toxicity of Mediastinal Radiotherapy: Which Are the Critical Structures?

Dirk Vordermark, Ines Seufert, Franz Schwab, Michael Flentje, Margret Kung, and Christiane Angermann

JCO May 20 2005: 3634–3636. [Full Text] [PDF]

In Reply:

M. Jacob Adams, Peter Mauch, Steven D. Colan, Nancy J. Tarbell, Lisa Diller, S. Ted Treves, and Steven E. Lipshultz

JCO May 20 2005: 3636. [Full Text] [PDF]

The Impact of Hormone Replacement Therapy on the Incidence of Breast Cancer in Norway

Kjersti Bakken, Eiliv Lund, and Anna Elise Eggen

JCO May 20 2005: 3636-a–3637. [Full Text] [PDF]

In Reply:

Kari Hemminki and Justo Lorenzo Bermego

JCO May 20 2005: 3637–3638. [Full Text] [PDF]

Correlates of SYT-SSX Fusion Type in Synovial Sarcoma: Getting More Complex But Also More Interesting?

Marc Ladanyi

JCO May 20 2005: 3638–3639. [Full Text] [PDF]

In Reply:

Louis Guillou and Jean-Michel Coindre

JCO May 20 2005: 3639–3640. [Full Text] [PDF]

Chemosensitivity and Resistance Assays: A Systematic Review?

Robert Nagourney

JCO May 20 2005: 3640–3641. [Full Text] [PDF]

In Vitro Drug Resistance Versus Chemosensitivity: Two Sides of Different Coins

John P. Fruehauf and David S. Alberts

JCO May 20 2005: 3641–3643. [Full Text] [PDF]

Chemotherapy Sensitivity and Response Assays: Are the ASCO Guidelines for Clinical Trial Design Too Restrictive?

H. Samuel Wieand

JCO May 20 2005: 3643–3644. [Full Text] [PDF]

Resisting a Fundamentalist Policy

Michael Castro

JCO May 20 2005: 3645–3646. [Full Text] [PDF]

In Reply:

Deborah Schrag, David J. Samson, Jerome Seidenfeld, Naomi Aronson, Harinder Garewal, Harold J. Burstein, Daniel D. Von Hoff, and Mark R. Somerfield

JCO May 20 2005: 3646–3648. [Full Text] [PDF]

Blue Dye of Choice for Lymphatic Mapping

Hernan I. Vargas

JCO May 20 2005: 3648. [Full Text] [PDF]

In Reply:

Chandrajit P. Raut, Kelly K. Hunt, and Henry M. Kuerer

JCO May 20 2005: 3648-a–3649. [Full Text] [PDF]

Ototoxicity of High-Dose Carboplatin

Christine Chevreau, Fabienne Thomas, Corinne Couteau, Florence Dalenc, Loic Mourey, and Etienne Chatelut

JCO May 20 2005: 3649–3650. [Full Text] [PDF]

In Reply:

Adrian Dubs and Christian Taverna

JCO May 20 2005: 3650–3651. [Full Text] [PDF]

Errata

ERRATUM

JCO May 20 2005: 3652. [Full Text] [PDF]

ERRATUM

JCO May 20 2005: 3652-a. [Full Text] [PDF]

ERRATUM

JCO May 20 2005: 3652-b. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.